Amesite (AMST) Registration filing summary

Company overview and business model

• Focuses on AI-powered solutions for the healthcare sector, especially post-acute care, having pivoted from an education-centric model in fiscal 2025.

• Operates two product lines under the NurseMagic™ brand: a B2C app for nurses/caregivers and a B2B platform for healthcare organizations.

• B2C app reduces documentation time and supports workflow; B2B platform targets operational efficiency, compliance, and data security for enterprises.

• Technology platform emphasizes rapid deployment, security, and compliance, with continuous feature updates and user-driven enhancements.

• Holds 14 U.S. patents and has pending applications covering AI, security, and learning systems.

Financial performance and metrics

• Reported net losses of approximately $3.6 million for the year ended June 30, 2025, and $4.4 million for 2024.

• Has not established a stable, recurring revenue base and expresses substantial doubt about its ability to continue as a going concern.

• Management plans to generate cash through financing transactions, but success is uncertain and not within full control.

Use of proceeds and capital allocation

• Will not receive proceeds from the resale of shares by selling stockholders; may receive up to $5.38 million if all warrants are exercised for cash.

• Proceeds from warrant exercises would be used to support operations, but timing and amount are unpredictable.